Risk stratification for cardiac death in hemodialysis patients without obstructive coronary artery disease

Kidney International

Volumn 79, Issue 3, 2011, Pages 363-371

  Nishimura, Masato ^a   Tsukamoto, Kazumasa ^b   Tamaki, Nagara ^c   Kikuchi, Kenjiro ^d   Iwamoto, Noriyuki ^e   Ono, Toshihiko ^e  

^a Toujinkai Hospital   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

^e Toujinkai Hospital   (Japan)

Author keywords

congestive heart failure; end stage renal disease; microangiopathy; myocardial infarction; sudden death

Indexed keywords

BETA METHYLIODOPHENYLPENTADECANOIC ACID I 123; PHOSPHATE; RADIOPHARMACEUTICAL AGENT; THALLIUM 201; UNCLASSIFIED DRUG;

AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG UPTAKE; FATTY ACID METABOLISM; FEMALE; HEART DEATH; HEART MUSCLE; HEART MUSCLE PERFUSION; HEMODIALYSIS PATIENT; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 78651406203     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.392     Document Type: Article

References (50)

1. US Renal Data System. USRDS 2006 Annual Data Report. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2006.
2. Ansell D, Roderick P, Hodsman A et al. UK Renal Registry 11th Annual Report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses. Nephron Clin Pract 2009; 111(Suppl 1): c113-c139.
3. Nakai S, Masakane I, Shigematsu T et al. An overview of regular dialysis treatment in Japan (As of 31 December 2007). Ther Apher Dial 2009; 13: 457-504.
4. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(Suppl 12): S16-S23.
5. Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 2001; 12: 1516-1523.
6. Manske CL, Thomas W, Wang Y et al. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993; 44: 617-621.
7. Rostand SG, Rutsky EA. Ischemic heart disease in chronic renal failure: management considerations. Semin Dial 1989; 2: 98-101.
8. Trivedi H, Xiang Q, Klein JP. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrol Dial Transplant 2009; 24: 258-266.
9. Nishimura M, Hashimoto T, Kobayashi H et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int 2004; 66: 811-819.
10. Nishimura M, Tsukamoto K, Hasebe N et al. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol 2008; 51: 139-145.
11. Nishimura M, Tokoro T, Nishida M et al. Prediction of cardiac death after coronary revascularization by myocardial fatty acid imaging in hemodialysis patients. Kidney Int 2008; 74: 513-520.
12. Nishimura M, Murase M, Hashimoto T et al. Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries. Kidney Int 2006; 69: 553-559.
13. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol, 2006, 291, H1489-H1506.
14. Zhou YT, Grayburn P, Karim A et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000; 97: 1784-1789.
15. Christoffersen C, Bollano E, Lindegaard ML et al. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003; 144: 3483-3490.
16. Boudina S, Sena S, O'Neill BT et al. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005; 112: 2686-2695.
17. Murray AJ, Anderson RE, Watson GC et al. Uncoupling proteins in human heart. Lancet 2004; 364: 1786-1788.
18. Murray AJ, Panagia M, Hauton D et al. Plasma fatty acids and peroxisome proliferators-activated receptor alpha in the control of myocardial uncoupling protein levels. Diabetes 2005; 54: 3496-3502.
19. Opie LH. The metabolic vicious cycle in heart failure. Lancet 2004; 364: 1733-1734.
20. Pitkanen OP, Raitakari OT, Niinikoski H et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996; 28: 1705-1711.
21. Laine H, Raitakari OT, Niinikoski H et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998; 32: 147-153.
22. Soman P, Dave DM, Udelson JE et al. Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive coronary artery disease. J Nucl Cardiol 2006; 13: 756-760.
23. DeFronzo RA, Alvestrand A, Smith D et al. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-568.
24. Wheatcroft SB, Williams IL, Shah AM et al. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 2003; 20: 255-268.
25. Jiang ZY, Lin YW, Clemont A et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999; 104: 447-457.
26. Balletshofer BM, Ritting K, Enderle MD et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000; 101: 1780-1784.
27. Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycemia. Diabetologia 1997; 40: 238-243.
28. Serne EH, Stehouwer CD, ter Maaten JC et al. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999; 99: 896-902.
29. Dagres N, Saller B, Haude M et al. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol 2004; 61: 724-731.
30. Amann K, Wiest G, Neusüß R et al. Changes in vascular architecture independent of blood pressure in experimental uremia. Vascular hypertrophy in uremia is independent of hypertension. Am J Hypertens 1995; 8: 409-417.
31. Barenbrock M, Spieker C, Laske V et al. Studies of vessel wall properties in hemodialysis patients. Kidney Int 1994; 45: 1397-1400.
32. Amann K, Wiest G, Zimmer G et al. Reduced capillary density in the myocardium of uremic rats - A stereological study. Kidney Int 1992; 42: 1079-1085.
33. Amann K, Breitbach M, Ritz E et al. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018-1022.
34. Razeghi P, Young ME, Cockrill TC et al. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Circulation 2002; 106: 407-411.
35. How OJ, Aasum E, Severson DL et al. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 2006; 55: 466-473.
36. Neitzel AS, Carley AN, Severson DL. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. Am J Physiol Endocrinol Metab 2003; 284: E358-E365.
37. Tuunanen H, Engblom E, Naum A et al. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction. J Card Fail 2006; 12: 2191-2196.
38. De Jongh RT, Serne EH, IJzerman RG et al. Free fatty acid levels modulate microvascular function. Diabetes 2004; 53: 2873-2882.
39. Lopaschuk GD, Belke DD, Gamble J et al. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994; 1213: 263-276.
40. Kataoka K, Nohara R, Hosokawa R et al. Myocardial lipid metabolism in compensated and advanced stages of heart failure: evaluation by canine pacing model with BMIPP. J Nucl Med 2001; 42: 124-129.
41. El Alaoui-Talibi Z, Landormy S, Loireau A et al. Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am J Physiol 1992; 262: H1068-H1074.
42. Allard MF, Schonekess BO, Henning SL et al. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 1994; 267: H742-H750.
43. Arnett EN, Isner JM, Redwood DR et al. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med 1979; 91: 350-356.
44. Porter TR, Sears T, Xie F et al. Intravascular ultrasound study of angiographically mildly diseased coronary arteries. J Am Coll Cardiol 1993; 22: 1858-1865.
45. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
46. Bonora E, Targger G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
47. Emoto M, Nishizawa Y, Maekawa K et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-822.
48. Shoji T, Emoto M, Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron 2001; 89: 348-349.
49. Cerqueira MD, Weissman NJ, Dilsizian V et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart-A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542.
50. Schiller NB, Shah P, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.